Answers are grounded in this paper and cite their sources.
Objectives Lung complications occur commonly post‐haematopoietic stem cell transplant (HCT) in children and contribute significantly to mortality. The development of biomarkers predictive of post‐HCT lung complications may improve outcomes for these children. Therefore, the primary objective of this study was to identify pre‐transplant plasma biomarkers predictive of lung complications in children undergoing HCT. Methods Plasma samples from 117 pre‐HCT patients were used to measure 78 soluble immune analytes, and extensive clinical metadata were retrospectively collected from the electronic medical record, including clinical characteristics of the post‐HCT lung complications. Results Firstly, we showed that the plasma cytokine signature of children undergoing HCT differed significantly between children depending on the indication for HCT (malignant vs non‐malignant). Secondly, we found that the plasma cytokine signature changed with the age of the patient. Thirdly, we showed that elevated pre‐HCT plasma levels of CXCL9 and Chitinase 3‐like 1, both induced by IFN‐γ, were predictive of post‐HCT lung complications in patients with a malignant indication for HCT [area under the curve (AUC): 0.70, P = 0.0007 and AUC: 0.68, P = 0.0016, respectively]. Conclusion In conclusion, we have identified two potential biomarkers of post‐HCT lung disease in paediatric patients and these require validation in future cohorts.
No takes yet. Share an insight, caveat, or question.
Walker et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: